glp 1 for high triglycerides Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Frontiers | Mechanisms of action

adults, or roughly 30 million people, currently take GLP-1 medicines, according to a widely cited survey from the policy and research organization KFF

Li et al., 2023b

The data paint a clearer picture of the demographics of those taking these drugs and the difficulties many are having with affordability

Second, among GLP-1 receptor agonists, only liraglutide and dulaglutide showed increased trends in the risks of overall thyroid disorders compared with placebo and other antidiabetic drugs

Similarly, certain foods or medications that interfere with B-vitamin absorption arent a concern since absorption isnt reliant on the gut here, but overall health habits matter